{"transactions":[{"id":3529283,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":157662,"kind":"organization","name":"Mellon Family Investment Co V","position":1,"cik":"0001774956","reported_name":"Mellon Family Investment Co V","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157663,"kind":"organization","name":"MFIC V, LLC","position":2,"cik":"0001775165","reported_name":"MFIC V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-13T21:03:05.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":1908450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"MFIC V, LLC, the general partner of Mellon Family Investment Company V, has sole voting and investment control with respect to shares of the Issuer's Common Stock held by Mellon Family Investment Company V."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":222816},"source":{"system":"sec-edgar","filing":"0000899243-19-013260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013260/doc4.xml","form_type":"4"}},{"id":3529282,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":157662,"kind":"organization","name":"Mellon Family Investment Co V","position":1,"cik":"0001774956","reported_name":"Mellon Family Investment Co V","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157663,"kind":"organization","name":"MFIC V, LLC","position":2,"cik":"0001775165","reported_name":"MFIC V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:03:05.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"MFIC V, LLC, the general partner of Mellon Family Investment Company V, has sole voting and investment control with respect to shares of the Issuer's Common Stock held by Mellon Family Investment Company V."}],"balance_after":347156,"source":{"system":"sec-edgar","filing":"0000899243-19-013260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013260/doc4.xml","form_type":"4"}},{"id":3529281,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":157662,"kind":"organization","name":"Mellon Family Investment Co V","position":1,"cik":"0001774956","reported_name":"Mellon Family Investment Co V","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157663,"kind":"organization","name":"MFIC V, LLC","position":2,"cik":"0001775165","reported_name":"MFIC V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:03:05.000Z","date":"2019-05-09","kind":"other","acquired":true,"shares":24340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Consists of shares transferred to Mellon Family Investment Company V by TPG Biotechnology Partners III, L.P. in connection with the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"MFIC V, LLC, the general partner of Mellon Family Investment Company V, has sole voting and investment control with respect to shares of the Issuer's Common Stock held by Mellon Family Investment Company V."}],"balance_after":247156,"source":{"system":"sec-edgar","filing":"0000899243-19-013260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013260/doc4.xml","form_type":"4"}},{"id":3529280,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":157662,"kind":"organization","name":"Mellon Family Investment Co V","position":1,"cik":"0001774956","reported_name":"Mellon Family Investment Co V","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157663,"kind":"organization","name":"MFIC V, LLC","position":2,"cik":"0001775165","reported_name":"MFIC V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:03:05.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":222816,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"MFIC V, LLC, the general partner of Mellon Family Investment Company V, has sole voting and investment control with respect to shares of the Issuer's Common Stock held by Mellon Family Investment Company V."}],"balance_after":222816,"source":{"system":"sec-edgar","filing":"0000899243-19-013260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013260/doc4.xml","form_type":"4"}}]}